The evolving epidemiology of hepatocellular carcinoma: a global perspective (Q38397998)

2 September 2017

1 reference

title

The evolving epidemiology of hepatocellular carcinoma: a global perspective (English)

1 reference

2 September 2017

1 reference

hepatocellular carcinoma

1 reference

Michael C Wallace

1 reference

2 September 2017

David Preen

series ordinal

1 reference

2 September 2017

Gary P Jeffrey

series ordinal

1 reference

2 September 2017

Leon A Adams

series ordinal

1 reference

2 September 2017

publication date

1 April 2015

1 reference

Expert Review of Gastroenterology & Hepatology

2 September 2017

published in

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

765-779

1 reference

Hepatocellular carcinoma: clinical frontiers and perspectives

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Economic burden of hepatitis C-associated diseases in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Evolving epidemiology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Obesity and hepatocellular carcinoma: hype and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Updated treatment approach to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Emerging trends in hepatocellular carcinoma incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Public health impact of antiviral therapy for hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma. A worldwide problem and the major risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

The global epidemiology of hepatocellular carcinoma: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Prospective cohort studies of association between family history of liver cancer and risk of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Family history of liver cancer and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Epidemiology of viral hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma: A global view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Gender disparity of hepatocellular carcinoma: the roles of sex hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: A population-based cohort study (JPHC Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Alcohol and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Obesity-associated mechanisms of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

A prospective study of red and processed meat intake in relation to cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Systematic review with meta-analysis: meat consumption and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma in patients without cirrhosis in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma and other malignancies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatic iron overload and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Malignant transformation of liver adenoma: an analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Mediterranean diet and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Future treatments of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1028363

10.1586/17474124.2015.1028363

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference